Precisio Biotix Therapeutics Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $1.48M

  • Investors
  • 1

Precisio Biotix Therapeutics General Information

Description

Operator of a pharmaceutical company intended to develop antibacterial biological therapy to combat antibiotic-resistant infections. The company's platform offers innovative lysin and phage technology to target and eliminate specific bacteria, enabling customers to develop new treatments for difficult-to-treat infections and combat the rising threat of antibiotic resistance.

Contact Information

Formerly Known As
Phagelux, Precisiobotix
Ownership Status
Privately Held (no backing)
Financing Status
Corporation
Corporate Office
  • Dover, DE
  • United States
+1 (216)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
  • Dover, DE
  • United States
+1 (216)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Precisio Biotix Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Grant 01-Jun-2025 $1.48M Completed Generating Revenue
To view Precisio Biotix Therapeutics’s complete valuation and funding history, request access »

Precisio Biotix Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Gates Foundation Not-For-Profit Venture Capital
To view Precisio Biotix Therapeutics’s complete investors history, request access »

Precisio Biotix Therapeutics Acquisitions (1)

Precisio Biotix Therapeutics’s most recent deal was a Merger/Acquisition with CC Bio. The deal was made on 01-Mar-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
CC Bio 01-Mar-2024 Merger/Acquisition Biotechnology
To view Precisio Biotix Therapeutics’s complete acquisitions history, request access »

Precisio Biotix Therapeutics Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
CC Bio Cambridge, United Kingdom 2018

Precisio Biotix Therapeutics FAQs

  • When was Precisio Biotix Therapeutics founded?

    Precisio Biotix Therapeutics was founded in 2013.

  • Where is Precisio Biotix Therapeutics headquartered?

    Precisio Biotix Therapeutics is headquartered in Dover, DE.

  • What industry is Precisio Biotix Therapeutics in?

    Precisio Biotix Therapeutics’s primary industry is Drug Discovery.

  • Is Precisio Biotix Therapeutics a private or public company?

    Precisio Biotix Therapeutics is a Private company.

  • What is Precisio Biotix Therapeutics’s current revenue?

    The current revenue for Precisio Biotix Therapeutics is .

  • Who are Precisio Biotix Therapeutics’s investors?

    Gates Foundation has invested in Precisio Biotix Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process